UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000055860 |
|---|---|
| Receipt number | R000063843 |
| Scientific Title | Japanese lung cancer registry study: Japanese Joint Committee of Lung Cancer Registry Database of patients who underwent resection in 2017 |
| Date of disclosure of the study information | 2024/10/17 |
| Last modified on | 2024/10/17 10:37:04 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Japanese lung cancer registry study: Japanese Joint Committee of Lung Cancer Registry Database of patients who underwent resection in 2017
Acronym
Japanese lung cancer registry study: Japanese Joint Committee of Lung Cancer Registry Database of patients who underwent resection in 2017
Scientific Title
Japanese lung cancer registry study: Japanese Joint Committee of Lung Cancer Registry Database of patients who underwent resection in 2017
Scientific Title:Acronym
Japanese lung cancer registry study: Japanese Joint Committee of Lung Cancer Registry Database of patients who underwent resection in 2017
Region
| Japan |
Condition
Condition
Lung Cancer
Classification by specialty
| Chest surgery |
Classification by malignancy
Malignancy
Genomic information
YES
Objectives
Narrative objectives1
The purpose of this study is to assess the clinicopathological features of resected primary lung cancer in 2017 using a large registry in Japan.
Basic objectives2
Others
Basic objectives -Others
These registration data will contribute to revising the UICC TNM classification.
Trial characteristics_1
Others
Trial characteristics_2
Developmental phase
Not applicable
Assessment
Primary outcomes
Surgical outcome for lung cancer treated in 2017
Key secondary outcomes
To identify predictive factors of surgical outcome for lung cancer treated in 2017
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patients aged 20 and over who underwent surgery for lung cancer in 2017.
Key exclusion criteria
Patients who refuse to participate in this research
Patients who underwent surgery for diagnostic purposes
Patients who underwent tumor resection using a bronchoscope
Patients who underwent local therapy that does not involve lung resection
Patients with primary tracheal cancer
Target sample size
15000
Research contact person
Name of lead principal investigator
| 1st name | Shun-ichi |
| Middle name | |
| Last name | Watanabe |
Organization
National Cancer Center Hospital
Division name
Department of Thoracic Surgery
Zip code
104-0045
Address
5-1-1, Tsukiji, Chuo-ku, Tokyo
TEL
03-3542-2511
syuwatan@ncc.go.jp
Public contact
Name of contact person
| 1st name | Masaya |
| Middle name | |
| Last name | Yotsukura |
Organization
National Cancer Center Hospital
Division name
Department of Thoracic Surgery
Zip code
104-0045
Address
5-1-1, Tsukiji, Chuo-ku, Tokyo
TEL
03-3542-2511
Homepage URL
https://haigan-touroku.jp/
haigan10@ml.res.ncc.go.jp
Sponsor or person
Institute
Japanese Joint Committee of Lung Cancer Registry
Institute
Department
Personal name
Funding Source
Organization
Japanese Joint Committee of Lung Cancer Registry
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Japanese Joint Committee of Lung Cancer Registry
Address
5-1-1, Tsukiji, Chuo-ku, Tokyo
Tel
03-3542-2511
haigan10@ml.res.ncc.go.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2024 | Year | 10 | Month | 17 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2024 | Year | 07 | Month | 29 | Day |
Date of IRB
| 2024 | Year | 07 | Month | 29 | Day |
Anticipated trial start date
| 2024 | Year | 08 | Month | 01 | Day |
Last follow-up date
| 2025 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
This study will collect clinical information on cases with surgery for lung cancer in 2017, including information on a 5-year follow-up period.
Management information
Registered date
| 2024 | Year | 10 | Month | 17 | Day |
Last modified on
| 2024 | Year | 10 | Month | 17 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063843
